Marshall Ken W. 4
4 · Aquestive Therapeutics, Inc. · Filed Mar 15, 2021
Insider Transaction Report
Form 4
Marshall Ken W.
SVP, Chief Commercial Officer
Transactions
- Award
Non-Qualified Stock Option (right to buy)
[F1]2021-03-11+40,000→ 40,000 totalExercise: $5.30Exp: 2031-03-11→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.
Signature
/s/ Robert Arnold, as Attorney-In-Fact|2021-03-15